BUZZ-Mizuho Securities raises PT on CVS Health to $95

Reuters12-11

** Mizuho Securities raises PT on U.S. health solutions company CVS Health CVS.N to $95 from $88

** New PT represents a 21.4% upside to the stock's last close

** Brokerage cites better retail earnings outlook and ongoing margin recovery at co's insurance unit

** On Tuesday, CVS raised its long‑term earnings forecast for the retail segment from mid‑single‑digit declines to at least flat, which brokerage sees as a key driver for multiple expansion

** CVS also said insurance unit Aetna's margin recovery is on track, helped by 2026 Medicare Advantage repricing and benefit changes, and its planned exit from the individual health exchange business

** 23 of 29 brokerages rate the stock "buy" or higher, 6 "hold"; median PT is $95 — data compiled by LSEG

** As of last close, CVS up 74.3% YTD

(Reporting by Pragyan Kalita in Bengaluru)

((Pragyan.Kalita@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590539706?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-11 00:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590539706","market":"nz","top_or_hot":-1,"title":"BUZZ-Mizuho Securities raises PT on CVS Health to $95","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Mizuho Securities raises PT on CVS Health to $95</title></head><body><p>** Mizuho Securities raises <span>PT </span>on U.S. health <span>solutions company </span>CVS Health <span>CVS.N</span> to $95 from $88  </p><p>** New PT represents a 21.4% upside to the stock's last close</p><p>** Brokerage <span>cites </span>better retail earnings outlook and ongoing margin recovery at <span>co's </span>insurance unit</p><p>** <span>On Tuesday, </span>CVS raised its long‑term earnings <span>forecast </span>for the retail segment from mid‑single‑digit declines to at least flat, which brokerage sees as a key driver for multiple expansion</p><p>** CVS <span>also </span>said insurance unit Aetna's margin recovery is on track, helped by 2026 Medicare Advantage repricing and benefit changes, and <span>its </span>planned exit from the individual health exchange business </p><p>** 23 of 29 brokerages rate the stock \"buy\" or higher, 6 \"hold\"; median PT is $95 — data compiled by LSEG</p><p>** As of last close, CVS up 74.3% YTD </p><p> (Reporting by Pragyan Kalita in Bengaluru)</p><p> ((Pragyan.Kalita@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Mizuho Securities raises PT on CVS Health to $95</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Mizuho Securities raises PT on CVS Health to $95\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-11 00:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Mizuho Securities raises PT on CVS Health to $95</title></head><body><p>** Mizuho Securities raises <span>PT </span>on U.S. health <span>solutions company </span>CVS Health <span>CVS.N</span> to $95 from $88  </p><p>** New PT represents a 21.4% upside to the stock's last close</p><p>** Brokerage <span>cites </span>better retail earnings outlook and ongoing margin recovery at <span>co's </span>insurance unit</p><p>** <span>On Tuesday, </span>CVS raised its long‑term earnings <span>forecast </span>for the retail segment from mid‑single‑digit declines to at least flat, which brokerage sees as a key driver for multiple expansion</p><p>** CVS <span>also </span>said insurance unit Aetna's margin recovery is on track, helped by 2026 Medicare Advantage repricing and benefit changes, and <span>its </span>planned exit from the individual health exchange business </p><p>** 23 of 29 brokerages rate the stock \"buy\" or higher, 6 \"hold\"; median PT is $95 — data compiled by LSEG</p><p>** As of last close, CVS up 74.3% YTD </p><p> (Reporting by Pragyan Kalita in Bengaluru)</p><p> ((Pragyan.Kalita@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0432979614.USD","symbol_name":"JPM GLOBAL HEALTHCARE \"A\" ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL4N3XG0WO:1","article_id":"2590539706","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590539706","pubTimestamp":1765384854,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Mizuho Securities raises PT on CVS Health to $95** Mizuho Securities raises PT on U.S. health solutions company CVS Health CVS.N to $95 from $88  ** New PT represents a 21.4% upside to the stock's last close** Brokerage cites better retail earnings outlook and ongoing margin recovery at co's insurance unit** On Tuesday, CVS raised its longterm earnings forecast for the retail segment from midsingledigit declines to at least flat, which brokerage sees as a key driver for multiple expansion** CVS also said insurance unit Aetna's margin recovery is on track, helped by 2026 Medicare Advantage repricing and benefit changes, and its planned exit from the individual health exchange business ** 23 of 29 brokerages rate the stock \"buy\" or higher, 6 \"hold\"; median PT is $95 — data compiled by LSEG** As of last close, CVS up 74.3% YTD   ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","BK4196":"保健护理服务","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4581":"高盛持仓","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4585":"ETF&股票定投概念","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","BK4504":"桥水持仓","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","BK4550":"红杉资本持仓","BK4588":"碎股","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","CVS":"西维斯健康","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC"},"translate_title":"BUZZ-瑞穗证券将CVS Health的PT提高至95美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVS":0.9},"content_text":"BUZZ-Mizuho Securities raises PT on CVS Health to $95** Mizuho Securities raises PT on U.S. health solutions company CVS Health CVS.N to $95 from $88  ** New PT represents a 21.4% upside to the stock's last close** Brokerage cites better retail earnings outlook and ongoing margin recovery at co's insurance unit** On Tuesday, CVS raised its long‑term earnings forecast for the retail segment from mid‑single‑digit declines to at least flat, which brokerage sees as a key driver for multiple expansion** CVS also said insurance unit Aetna's margin recovery is on track, helped by 2026 Medicare Advantage repricing and benefit changes, and its planned exit from the individual health exchange business ** 23 of 29 brokerages rate the stock \"buy\" or higher, 6 \"hold\"; median PT is $95 — data compiled by LSEG** As of last close, CVS up 74.3% YTD  (Reporting by Pragyan Kalita in Bengaluru) ((Pragyan.Kalita@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590539706","isCrawlerRequest":true}